Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice.
暂无分享,去创建一个
[1] N. Rothwell,et al. Tumor Necrosis Factor α Is a Critical Component of Interleukin 13–Mediated Protective T Helper Cell Type 2 Responses during Helminth Infection , 1999, The Journal of experimental medicine.
[2] M. Feldmann,et al. Therapeutic antibodies elicited by immunization against TNF-α , 1999, Nature Biotechnology.
[3] J. Renauld,et al. IL‐9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice , 1999, European journal of immunology.
[4] R. Kiss,et al. Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. , 1999, The Journal of clinical investigation.
[5] J. Renauld,et al. Interleukin 9–induced In Vivo Expansion of the B-1 Lymphocyte Population , 1999, The Journal of experimental medicine.
[6] A. Burny,et al. Anti-IFNα immunization raises the IFNα-neutralizing capacity of serum — an adjuvant to antiretroviral tritherapy , 1999 .
[7] K. Else,et al. Mast cells, eosinophils and antibody‐mediated cellular cytotoxicity are not critical in resistance to Trichuris muris , 1999, Parasite immunology.
[8] M. van de Rijn,et al. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. , 1998, American journal of respiratory cell and molecular biology.
[9] R. Flavell,et al. Expression of Interleukin 9 in the Lungs of Transgenic Mice Causes Airway Inflammation, Mast Cell Hyperplasia, and Bronchial Hyperresponsiveness , 1998, The Journal of experimental medicine.
[10] K. Buetow,et al. Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal region. , 1998, Genomics.
[11] J. Renauld,et al. Interleukin-9 Enhances Resistance to the Intestinal Nematode Trichuris muris , 1998, Infection and Immunity.
[12] J. Renauld,et al. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. , 1998, Journal of immunology.
[13] R. Grencis,et al. A critical role for IL-13 in resistance to intestinal nematode infection. , 1998, Journal of immunology.
[14] K. Buetow,et al. Interleukin 9: a candidate gene for asthma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Mouritsen,et al. Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope. , 1997, Molecular immunology.
[16] F. Finkelman,et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. , 1997, Annual review of immunology.
[17] K. Else,et al. Interleukin‐12 promotes a chronic intestinal nematode infection , 1997, European journal of immunology.
[18] P. Hindersson,et al. Breaking of B cell tolerance toward a highly conserved self protein. , 1996, Journal of immunology.
[19] R. Pal,et al. A vaccine that prevents pregnancy in women. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. D. Neely,et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. , 1994, Science.
[21] J. Renauld,et al. Thymic lymphomas in interleukin 9 transgenic mice. , 1994, Oncogene.
[22] M. Satoh,et al. Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen , 1994, The Journal of experimental medicine.
[23] R. Zinkernagel,et al. Virus or a hapten‐carrier complex can activate autoreactive B cells by providing linked T help , 1994, European journal of immunology.
[24] F. Finkelman,et al. Cytokine-mediated regulation of chronic intestinal helminth infection , 1994, The Journal of experimental medicine.
[25] M. Röllinghoff,et al. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. , 1993, Immunobiology.
[26] R. Zinkernagel,et al. The influence of antigen organization on B cell responsiveness. , 1993, Science.
[27] J. Renauld,et al. Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line , 1991, The Journal of experimental medicine.
[28] P. Coulie,et al. In vivo polyclonal B-lymphocyte activation elicited by murine viruses , 1990, Journal of virology.
[29] C. Uyttenhove,et al. Functional and biochemical characterization of mouse P40/IL-9 receptors. , 1990, Journal of immunology.
[30] C. Uyttenhove,et al. Mast cell growth‐enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9) , 1990, European journal of immunology.
[31] C. Uyttenhove,et al. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. F. Chang,et al. Active immunization of heifers against luteinizing hormone-releasing hormone, human chorionic gonadotropin and bovine luteinizing hormone. , 1988, Journal of animal science.
[33] B. Stockinger,et al. Induction of an immune response to a self antigen , 1988, European journal of immunology.
[34] U. Landegren. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. , 1984, Journal of immunological methods.
[35] D. Wakelin. Acquired immunity to Trichuris muris in the albino laboratory mouse , 1967, Parasitology.